Literature DB >> 16732206

Sildenafil-associated consecutive nonarteritic anterior ischaemic optic neuropathy, cilioretinal artery occlusion, and central retinal vein occlusion in a haemodialysis patient.

S Gedik, G Yilmaz, Y A Akova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16732206     DOI： 10.1038/sj.eye.6702445

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  7 in total

1.  [Acute monocular loss of vision : Differential diagnostic considerations apart from the internistic etiological clarification].

Authors:  A Rickmann; M A Macek; P Szurman; K Boden
Journal:  Ophthalmologe       Date:  2018-08       Impact factor: 1.059

Review 2.  Vision disorders and phosphodiesterase type 5 inhibitors: a review of the evidence to date.

Authors:  Alan M Laties
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 3.  Phosphodiesterase type 5 inhibitors, visual changes, and nonarteritic anterior ischemic optic neuropathy: is there a link?

Authors:  Konstantinos Hatzimouratidis
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 3.092

Review 4.  Phosphodiesterase Type 5 Inhibitors and Visual Side Effects: A Narrative Review.

Authors:  Francisco Barroso; João Crispim Ribeiro; Eduardo P Miranda
Journal:  J Ophthalmic Vis Res       Date:  2021-04-29

5.  Central Retinal Artery Occlusion Associated with Sildenafil Overdose.

Authors:  Mojtaba Abrishami; Seyedeh Maryam Hosseini; Hamid Mohseni; Majid Razavi; Amir Ghaffarian Mashhadi Nejad; Mohammad Baghi Yazdi; Ghodsieh Zamani
Journal:  Case Rep Ophthalmol Med       Date:  2021-09-04

6.  Case Report: Central retinal artery occlusion following sildenafil intake.

Authors:  Anis Mahmoud; Fatma Abid; Molka Khairallah; Fatma Sakji; Hassen Ibn Hadj Amor; Hala Attia; Sameh Mbarek; Riadh Messaoud
Journal:  F1000Res       Date:  2022-06-01

Review 7.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.